Literature DB >> 33557778

The association between clinical laboratory data and chest CT findings explains disease severity in a large Italian cohort of COVID-19 patients.

Simone Canovi1, Giulia Besutti2,3, Efrem Bonelli4,2, Valentina Iotti2, Marta Ottone5, Laura Albertazzi4, Alessandro Zerbini6, Pierpaolo Pattacini2, Paolo Giorgi Rossi5, Rossana Colla4, Tommaso Fasano4.   

Abstract

BACKGROUND: Laboratory data and computed tomography (CT) have been used during the COVID-19 pandemic, mainly to determine patient prognosis and guide clinical management. The aim of this study was to evaluate the association between CT findings and laboratory data in a cohort of COVID-19 patients.
METHODS: This was an observational cross-sectional study including consecutive patients presenting to the Reggio Emilia (Italy) province emergency rooms for suspected COVID-19 for one month during the outbreak peak, who underwent chest CT scan and laboratory testing at presentation and resulted positive for SARS-CoV-2.
RESULTS: Included were 866 patients. Total leukocytes, neutrophils, C-reactive protein (CRP), creatinine, AST, ALT and LDH increase with worsening parenchymal involvement; an increase in platelets was appreciable with the highest burden of lung involvement. A decrease in lymphocyte counts paralleled worsening parenchymal extension, along with reduced arterial oxygen partial pressure and saturation. After correcting for parenchymal extension, ground-glass opacities were associated with reduced platelets and increased procalcitonin, consolidation with increased CRP and reduced oxygen saturation.
CONCLUSIONS: Pulmonary lesions induced by SARS-CoV-2 infection were associated with raised inflammatory response, impaired gas exchange and end-organ damage. These data suggest that lung lesions probably exert a central role in COVID-19 pathogenesis and clinical presentation.

Entities:  

Keywords:  COVID-19; Clinical laboratory; Computed tomography

Year:  2021        PMID: 33557778     DOI: 10.1186/s12879-021-05855-9

Source DB:  PubMed          Journal:  BMC Infect Dis        ISSN: 1471-2334            Impact factor:   3.090


  6 in total

1.  Association of Inflammatory Markers with COVID-19 Outcome among Hospitalized Patients: Experience from a Tertiary Healthcare Center in Western India.

Authors:  Varatharajan Sakthivadivel; Gopal Krishana Bohra; Nachimuthu Maithilikarpagaselvi; Satyendra Khichar; Mahadev Meena; Naveenraj Palanisamy; Archana Gaur; Mahendra Kumar Garg
Journal:  Maedica (Bucur)       Date:  2021-12

2.  Clinical and chest computed tomography features of patients suffering from mild and severe COVID-19 at Fayoum University Hospital in Egypt.

Authors:  Ahmed Ismail; Ahmed S Doghish; Walid F Elkhatib; Ahmed M Magdy; Eman E Mahmoud; Mona I Ahmed; Mahmoud A F Khalil
Journal:  PLoS One       Date:  2022-07-08       Impact factor: 3.752

3.  Chest CT severity score: assessment of COVID‑19 severity and short-term prognosis in hospitalized Iranian patients.

Authors:  Alireza Aziz-Ahari; Mahsa Keyhanian; Setareh Mamishi; Shima Mahmoudi; Ebrahim Ebrahimi Bastani; Fatemeh Asadi; Mohammadreza Khaleghi
Journal:  Wien Med Wochenschr       Date:  2022-02-08

Review 4.  A Review of Routine Laboratory Biomarkers for the Detection of Severe COVID-19 Disease.

Authors:  Keynaz Keykavousi; Fahimeh Nourbakhsh; Nooshin Abdollahpour; Farzaneh Fazeli; Alireza Sedaghat; Vahid Soheili; Amirhossein Sahebkar
Journal:  Int J Anal Chem       Date:  2022-10-11       Impact factor: 1.698

5.  Profiling of Lactate Dehydrogenase Isoenzymes in COVID-19 Disease.

Authors:  Erika Dzsudzsák; Renáta Sütő; Marianna Pócsi; Miklós Fagyas; Zoltán Szentkereszty; Béla Nagy
Journal:  EJIFCC       Date:  2021-12-07

6.  Inflammatory burden and persistent CT lung abnormalities in COVID-19 patients.

Authors:  Giulia Besutti; Paolo Giorgi Rossi; Marta Ottone; Lucia Spaggiari; Simone Canovi; Filippo Monelli; Efrem Bonelli; Tommaso Fasano; Nicola Sverzellati; Andrea Caruso; Nicola Facciolongo; Giulia Ghidoni; Anna Simonazzi; Mauro Iori; Andrea Nitrosi; Stefania Fugazzaro; Stefania Costi; Stefania Croci; Elisabetta Teopompi; Annalisa Gallina; Marco Massari; Giovanni Dolci; Fabio Sampaolesi; Pierpaolo Pattacini; Carlo Salvarani
Journal:  Sci Rep       Date:  2022-03-11       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.